BANK OF AMERICA CORP /DE/ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$7,866
-15.5%
34,201
+30.1%
0.00%
Q1 2023$9,306
-28.0%
26,288
-34.9%
0.00%
Q4 2022$12,926
-71.9%
40,394
-36.1%
0.00%
Q3 2022$46,000
-56.6%
63,203
-46.4%
0.00%
Q2 2022$106,000
+221.2%
117,868
+424.2%
0.00%
Q1 2022$33,000
-54.8%
22,485
-32.8%
0.00%
Q4 2021$73,000
-26.3%
33,475
+20.1%
0.00%
Q3 2021$99,000
-34.4%
27,868
+5.7%
0.00%
Q2 2021$151,000
-43.0%
26,370
-48.3%
0.00%
Q1 2021$265,000
+813.8%
51,053
+313.1%
0.00%
Q4 2020$29,00012,359
+13944.3%
0.00%
Q3 2020$0
-100.0%
88
-99.1%
0.00%
Q2 2020$19,000
+850.0%
9,864
+1401.4%
0.00%
Q1 2020$2,000
-66.7%
657
-74.2%
0.00%
Q4 2019$6,000
-53.8%
2,542
-59.6%
0.00%
Q3 2019$13,000
+30.0%
6,285
+47.1%
0.00%
Q2 2019$10,000
-67.7%
4,272
-45.3%
0.00%
Q1 2019$31,000
+287.5%
7,803
+145.8%
0.00%
Q2 2018$8,000
+300.0%
3,175
+485.8%
0.00%
Q1 2018$2,000
-33.3%
542
-22.9%
0.00%
Q4 2017$3,000
-25.0%
703
+24.9%
0.00%
Q3 2017$4,000
+300.0%
563
+120.8%
0.00%
Q2 2017$1,000
-50.0%
2550.0%0.00%
Q1 2017$2,000
-33.3%
255
-45.4%
0.00%
Q4 2016$3,000
+200.0%
467
+61.6%
0.00%
Q3 2016$1,000
-50.0%
289
-55.3%
0.00%
Q2 2016$2,000
-84.6%
647
-77.2%
0.00%
Q1 2016$13,0002,8420.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders